<DOC>
	<DOCNO>NCT00435656</DOCNO>
	<brief_summary>In research project , study genetic determinant influence pharmacokinetics antiretroviral drug use treatment disease cause HIV .</brief_summary>
	<brief_title>Pharmacogenetics Antiretroviral Drugs</brief_title>
	<detailed_description>The development new active substance continuous source progress pharmacotherapy . However , search optimal use exist molecule constitute another possible way progress . In particular field anti-infectious therapy , optimization treatment could minimize emergence resistance phenomenon require continuous development new active molecule . Pharmacogenetics scientific discipline seek improve response drug therapy ( well clinical efficiency reduction side effect ) take consideration genetic characteristic patient . Drugs narrow therapeutic index constitute main target emerge field . The combination therapeutic drug monitoring pharmacogenetics already allow optimize use drug among oral anticoagulant , immunosuppressant , antiepileptic , antidepressors , antibiotic antiviralsâ€¦ . In research project , study genetic determinant influence pharmacokinetics antiretroviral drug use treatment disease cause HIV . We put particular emphasis viral protease inhibitor ( atazanavir , saquinavir , lopinavir , ritonavir ) non-nucleosides reverse transcriptase inhibitor ( nevirapine efavirenz ) . For drug , clinician often face double therapeutic risk , either insufficient dosing ( clinical inefficacy emergence resistance ) excessive dose ( toxicity ) . The optimization drug dose especially crucial drug often represent last choice multi-resistant patient .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIV infect patient pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Human immunodeficiency virus</keyword>
</DOC>